Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Price
Target price
€2.98

€2.98

-1.950%
-0.06
-1.950%
€8.71
 
25.04.24 / Tradegate WKN: A3EMJP / Symbol: LPTX / Name: Leap Therapeutics / Stock / Micro Cap /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.

Leap Therapeutics Inc. Stock

We can see a decrease in the price for Leap Therapeutics Inc.. Compared to yesterday it has lost -€0.060 (-1.950%).
With 7 Buy predictions and not the single Sell prediction the community is currently very high on Leap Therapeutics Inc..
With a target price of 8 € there is potential for a 168.46% increase which would mean more than doubling the current price of 2.98 € for Leap Therapeutics Inc..
So far the community has only identified positive things for Leap Therapeutics Inc. stock. The most positive votes were given for criterium "Worthwhile Investment for the next years".

Pros and Cons of Leap Therapeutics Inc. in the next few years

Pros
?
S********** s********
?
G***** c******* t* c**********
?
C******** o* t** e**********
Cons
?
W********* I********* f** t** n*** y****
?
M***** P*******
?
B****
Tell us your opinion to access the 'Wisdom of the Crowds'

Comments

Prediction Buy
Perf. (%) 44.55%
Target price 6.448
Change
Ends at 19.03.25

Leap Therapeutics, Inc. (NASDAQ: LPTX) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $7.00 price target on the stock.
Ratings data for LPTX provided by MarketBeat
Show more

Prediction Buy
Perf. (%) 58.51%
Target price 10.966
Change
Ends at 20.11.24

Leap Therapeutics, Inc. (NASDAQ: LPTX) had its price target lowered by analysts at Mizuho from $20.00 to $12.00. They now have a "buy" rating on the stock.
Ratings data for LPTX provided by MarketBeat
Show more

Prediction Buy
Perf. (%) 113.14%
Target price 16.214
Change
Ends at 14.11.24

Leap Therapeutics, Inc. (NASDAQ: LPTX) had its price target lowered by analysts at Raymond James from $18.50 to $17.50. They now have an "outperform" rating on the stock.
Ratings data for LPTX provided by MarketBeat
Show more